Feasibility and Therapeutic Potential of 177 Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers: A Preliminary Study.
| Autor: | Assadi, Majid, Rekabpour, Seyed Javad, Jafari, Esmail, Divband, GhasemAli, Nikkholgh, Babak, Amini, Hamidreza, Kamali, Hassan, Ebrahimi, Sakineh, Shakibazad, Nader, Jokar, Narges, Nabipour, Iraj, Ahmadzadehfar, Hojjat |
|---|---|
| Zdroj: | Clinical Nuclear Medicine; Nov2021, Vol. 46 Issue 11, pe523-e530, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|